|
|
Volumn 2, Issue , 1997, Pages 1-28
|
|
Treatments for obesity
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID;
ANTIOBESITY AGENT;
BROMOCRIPTINE;
CYCLOHEXYL[4 [2 [2 HYDROXY 3 (4 HYDROXYPHENOXY)PROPYLAMINO]ETHYL]PHENOXYMETHYL]PHOSPHINIC ACID;
DEXFENFLURAMINE;
ENTEROSTATIN;
ENZYME INHIBITOR;
FLUASTERONE;
FLUOXETINE;
LEPTIN;
LEPTIN RECEPTOR;
N [4 [2 [[2 HYDROXY 3 (4 HYDROXYPHENOXY)PROPYL]AMINO]ETHYL]PHENYL]BENZENESULFONAMIDE;
NGD 95 1;
PHENETHYLAMINE DERIVATIVE;
PHENTERMINE;
RF 1051;
SEROTONIN 1 AGONIST;
SIBUTRAMINE;
TETRAHYDROLIPSTATIN;
UNCLASSIFIED DRUG;
[[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER;
BODY WEIGHT;
CLINICAL TRIAL;
DIABETES MELLITUS;
ENERGY EXPENDITURE;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
MORBIDITY;
MORTALITY;
OBESITY;
PREVALENCE;
REVIEW;
WEIGHT REDUCTION;
|
|
EID: 0031443078
PISSN: 13619195
EISSN: None
Source Type: Journal
DOI: 10.1517/14728214.2.1.1 Document Type: Review |
|
Times cited : (2)
|
|
References (115)
|
